Patents by Inventor Ryan Benjamin Abbott

Ryan Benjamin Abbott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10858422
    Abstract: Described herein are peptides and antibodies for prevention and/or therapeutic treatment of mammals, including humans, against systemic lupus erythematosus, as well as diagnosing the presence or absence of antibodies related to increased or decreased risk of developing SLE and/or to disease grading, staging, and/or prognosis.
    Type: Grant
    Filed: May 31, 2019
    Date of Patent: December 8, 2020
    Assignee: Abcentra, LLC
    Inventors: Jan Nilsson, Ryan Benjamin Abbott, Bertrand C. Liang, Christopher John Farina, Stacey Ruiz
  • Patent number: 10434141
    Abstract: Described herein are peptides and antibodies for prevention and/or therapeutic treatment of mammals, including humans, against systemic lupus erythematosus, as well as diagnosing the presence or absence of antibodies related to increased or decreased risk of developing SLE and/or to disease grading, staging, and/or prognosis.
    Type: Grant
    Filed: May 31, 2017
    Date of Patent: October 8, 2019
    Assignee: Abcentra, LLC
    Inventors: Jan Nilsson, Ryan Benjamin Abbott
  • Publication number: 20190284268
    Abstract: Described herein are peptides and antibodies for prevention and/or therapeutic treatment of mammals, including humans, against systemic lupus erythematosus, as well as diagnosing the presence or absence of antibodies related to increased or decreased risk of developing SLE and/or to disease grading, staging, and/or prognosis.
    Type: Application
    Filed: May 31, 2019
    Publication date: September 19, 2019
    Applicant: Abcentra, LLC
    Inventors: Jan Nilsson, Ryan Benjamin Abbott, Bertrand C. Liang, Christopher John Farina, Stacey Ruiz